Lukas Reissig

Dr. Lukas Reissig

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 February 2017 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
RWRobert Wilson
Robert Wilson
SGStefan H. Geyer
Stefan H. Geyer
LRLukas Reissig
Lukas Reissig
JRJulia Rose
Julia Rose
DSDorota Szumska
Dorota Szumska
WWWolfgang J. Weninger
Wolfgang J. Weninger
Background: Identifying genes that are essential for mouse embryonic development and survival through term is a powerful and unbiased way to discover possible genetic determinants of human developmental disorders. Characterising the changes in mouse embryos that result from ablation of lethal genes is a necessary first step towards uncovering their role in normal embryonic development and establishing any correlates amongst human congenital abnormalities. Methods: Here we present results gathered to date in the Deciphering the Mechanisms of Developmental Disorders (DMDD) programme, cataloguing the morphological defects identified from comprehensive imaging of 220 homozygous mutant and 114 wild type embryos from 42 lethal and subviable lines, analysed at E14.5. Results: Virtually all mutant embryos show multiple abnormal phenotypes and amongst the 42 lines these affect most organ systems. Within each mutant line, the phenotypes of individual embryos form distinct but overlapping sets. Subcutaneous edema, malformations of the heart or great vessels, abnormalities in forebrain morphology and the musculature of the eyes are all prevalent phenotypes, as is loss or abnormal size of the hypoglossal nerve. Conclusions: Overall, the most striking finding is that no matter how profound the malformation, each phenotype shows highly variable penetrance within a mutant line. These findings have challenging implications for efforts to identify human disease correlates.

5 April 2021 in Acta Physiologica
Verified
Journal Article
Open access
PDF file
CHClara Höbart
Clara Höbart
NRNatalia S. Rojas‐Galvan
Natalia S. Rojas‐Galvan
CCCosmin Ciotu
Cosmin Ciotu
IAIbrahim Aykac
Ibrahim Aykac
LRLukas Reissig
Lukas Reissig
SHStefan Heber
Stefan Heber
Aim: There is mounting evidence that TRPA1 has a role in cardiac physiology and pathophysiology. We aim to clarify the site of TRPA1 expression in the heart and in particular whether the channel is expressed in cardiomyocytes.Methods: Due to the high calcium conductance of TRPA1, and marginal calcium changes being detectable, microfluorimetry in primary mouse cardiomyocytes, and in the cardiomyocyte cell lines H9c2 and HL‐1, was applied. TRPA1 mRNA in mouse and human hearts, primary cardiomyocytes, and the cardiac cell lines were quantified. Dorsal root ganglia served as control for both methods.Results: In addition to AITC, the more potent and specific TRPA1 agonists JT010 and PF‐4840154 failed to elicit a TRPA1‐mediated response in native and electrically paced primary cardiomyocytes, and the cardiomyocyte cell lines H9c2 and HL‐1. There were only marginal levels of TRPA1 mRNA in cardiomyocytes and cardiac cell lines, also in conditions of cell differentiation or inflammation, which might occur in pathophysiological conditions. Similarly, TRPV1 agonist capsaicin did not activate primary mouse cardiomyocytes, did not alter electrically paced activity in these, and did not activate H9c2 cells or alter spontaneous activity of HL‐1 cells. Human pluripotent stem cells differentiated to cardiomyocytes had no relevant TRPA1 mRNA levels. Also in human post‐mortem heart samples, TRPA1 mRNA levels were substantially lower compared with the respective dorsal root ganglion.Conclusion: The results do not question a role of TRPA1 in the heart but exclude a direct effect in cardiomyocytes.

25 April 2024 in Brain Stimulation
Verified
Journal Article
Open access
BKBettina Kronsteiner
Bettina Kronsteiner
GRGénova Carrero Rojas
Génova Carrero Rojas
LRLukas Reissig
Lukas Reissig
AMAtieh Seyedian Moghaddam
Atieh Seyedian Moghaddam
KSKaroline Maria Schwendt
Karoline Maria Schwendt
WWWolfgang J. Weninger
Wolfgang J. Weninger
Electrical stimulation of the vagus nerve (VN) is a therapy for epilepsy, obesity, depression, and heart diseases. However, whole nerve stimulation leads to side effects. We examined the neuroanatomy of the mid-cervical segment of the human VN and its superior cardiac branch to gain insight into the side effects of VN stimulation and aid in developing targeted stimulation strategies. Nerve specimens were harvested from eight human body donors, then subjected to immunofluorescence and semiautomated quantification to determine the signature, quantity, and spatial distribution of different axonal categories. The right and left cervical VN (cVN) contained a total of 25,489 ± 2,781 and 23,286 ± 3,164 fibers, respectively. Two-thirds of the fibers were unmyelinated and one-third were myelinated. About three-quarters of the fibers in the right and left cVN were sensory (73.9 ± 7.5% versus 72.4 ± 5.6%), while 13.2 ± 1.8% versus 13.3 ± 3.0% were special visceromotor and parasympathetic, and 13 ± 5.9% versus 14.3 ± 4.0% were sympathetic. Special visceromotor and parasympathetic fibers formed clusters. The superior cardiac branches comprised parasympathetic, vagal sensory, and sympathetic fibers with the left cardiac branch containing more sympathetic fibers than the right (62.7 ± 5.4% versus 19.8 ± 13.3%), and 50% of the left branch contained sensory and sympathetic fibers only. The study indicates that selective stimulation of vagal sensory and motor fibers is possible. However, it also highlights the potential risk of activating sympathetic fibers in the superior cardiac branch, especially on the left side.

Verified
Journal Article
Open access
PDF file
WWWolfgang J. Weninger
Wolfgang J. Weninger
BMBarbara Maurer-Gesek
Barbara Maurer-Gesek
LRLukas Reissig
Lukas Reissig
FPFabrice Prin
Fabrice Prin
RWRobert Wilson
Robert Wilson
SGStefan Geyer
Stefan Geyer
The article will briefly introduce the high-resolution episcopic microscopy (HREM) technique and will focus on its potential for researching cardiovascular development and remodelling in embryos of biomedical model organisms. It will demonstrate the capacity of HREM for analysing the cardiovascular system of normally developed and genetically or experimentally malformed zebrafish, frog, chick and mouse embryos in the context of the whole specimen and will exemplarily show the possibilities HREM offers for comprehensive visualisation of the vasculature of adult human skin. Finally, it will provide examples of the successful application of HREM for identifying cardiovascular malformations in genetically altered mouse embryos produced in the deciphering the mechanisms of developmental disorders (DMDD) program.

1 August 2020 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
PDPhilippe Dodier
Philippe Dodier
FWFabian Winter
Fabian Winter
TAThomas Auzinger
Thomas Auzinger
GMGabriel Mistelbauer
Gabriel Mistelbauer
JFJosa M Frischer
Josa M Frischer
GBGerhard Bavinzski
Gerhard Bavinzski

15 November 2016 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
RWRobert Wilson
Robert Wilson
SGStefan Geyer
Stefan Geyer
LRLukas Reissig
Lukas Reissig
JRJulia Rose
Julia Rose
DSDorota Szumska
Dorota Szumska
WWWolfgang J. Weninger
Wolfgang J. Weninger
Background: Identifying genes that are essential for mouse embryonic development and survival through term is a powerful and unbiased way to discover possible genetic determinants of human developmental disorders. Characterising the changes in mouse embryos that result from ablation of lethal genes is a necessary first step towards uncovering their role in normal embryonic development and establishing any correlates amongst human congenital abnormalities. Methods: Here we present results gathered to date in the Deciphering the Mechanisms of Developmental Disorders (DMDD) programme, cataloguing the morphological defects identified from comprehensive imaging of 220 homozygous mutant embryos from 42 lethal and subviable lines, analysed at E14.5. Results: Virtually all embryos show multiple abnormal phenotypes and amongst the 42 lines these affect most organ systems. Within each mutant line, the phenotypes of individual embryos form distinct but overlapping sets. Subcutaneous edema, malformations of the heart or great vessels, abnormalities in forebrain morphology and the musculature of the eyes are all prevalent phenotypes, as is loss or abnormal size of the hypoglossal nerve. Conclusions: Overall, the most striking finding is that no matter how profound the malformation, each phenotype shows highly variable penetrance within a mutant line. These findings have challenging implications for efforts to identify human disease correlates.